These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26916712)

  • 41. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?
    Saunders P; Goodman AL; Smith CJ; Marshall N; O'Connor JL; Lampe FC; Johnson MA
    HIV Med; 2016 Jan; 17(1):18-27. PubMed ID: 26140659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is substance use associated with HIV cascade outcomes in Latin America?
    De Boni RB; Peratikos MB; Shepherd BE; Grinsztejn B; Cortés C; Padgett D; Gotuzzo E; Belaunzarán-Zamudio PF; Rebeiro PF; Duda SN; McGowan CC;
    PLoS One; 2018; 13(3):e0194228. PubMed ID: 29543857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda.
    Santos GM; Emenyonu NI; Bajunirwe F; Rain Mocello A; Martin JN; Vittinghoff E; Bangsberg DR; Hahn JA
    Drug Alcohol Depend; 2014 Jan; 134():151-157. PubMed ID: 24169501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of different types of alcoholic beverages on disrupting highly active antiretroviral treatment (HAART) outcome.
    Míguez-Burbano MJ; Lewis JE; Fishman J; Asthana D; Malow RM
    Alcohol Alcohol; 2009; 44(4):366-71. PubMed ID: 19454401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of sex and alcohol use on antiretroviral therapy outcomes in Botswana: a cohort study.
    Gross R; Bellamy SL; Ratshaa B; Han X; Steenhoff AP; Mosepele M; Bisson GP
    Addiction; 2017 Jan; 112(1):73-81. PubMed ID: 27447841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV.
    Barai N; Monroe A; Lesko C; Lau B; Hutton H; Yang C; Alvanzo A; McCaul ME; Chander G
    AIDS Behav; 2017 Jul; 21(7):1836-1845. PubMed ID: 27752873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multi-dimensional risk factor patterns associated with non-use of highly active antiretroviral therapy among human immunodeficiency virus-infected women.
    Jones AS; Lillie-Blanton M; Stone VE; Ip EH; Zhang Q; Wilson TE; Cohen MH; Golub ET; Hessol NA
    Womens Health Issues; 2010 Sep; 20(5):335-42. PubMed ID: 20579905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alcohol consumption and CD4 T-cell count response among persons initiating antiretroviral therapy.
    Kowalski S; Colantuoni E; Lau B; Keruly J; McCaul ME; Hutton HE; Moore RD; Chander G
    J Acquir Immune Defic Syndr; 2012 Dec; 61(4):455-61. PubMed ID: 22955054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa.
    Jaquet A; Ekouevi DK; Bashi J; Aboubakrine M; Messou E; Maiga M; Traore HA; Zannou MD; Guehi C; Ba-Gomis FO; Minga A; Allou G; Eholie SP; Bissagnene E; Sasco AJ; Dabis F
    Addiction; 2010 Aug; 105(8):1416-21. PubMed ID: 20528816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study.
    Marconi VC; Grandits GA; Weintrob AC; Chun H; Landrum ML; Ganesan A; Okulicz JF; Crum-Cianflone N; O'Connell RJ; Lifson A; Wortmann GW; Agan BK;
    AIDS Res Ther; 2010 May; 7():14. PubMed ID: 20507622
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alcohol consumption is associated with poor health in HIV clinic patient population: a behavioral surveillance study.
    Shacham E; Agbebi A; Stamm K; Overton ET
    AIDS Behav; 2011 Jan; 15(1):209-13. PubMed ID: 20013042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men.
    Justice AC; McGinnis KA; Tate JP; Braithwaite RS; Bryant KJ; Cook RL; Edelman EJ; Fiellin LE; Freiberg MS; Gordon AJ; Kraemer KL; Marshall BD; Williams EC; Fiellin DA
    Drug Alcohol Depend; 2016 Apr; 161():95-103. PubMed ID: 26861883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection.
    Chander G; Lau B; Moore RD
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):411-7. PubMed ID: 17099312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003.
    Seaberg EC; Muñoz A; Lu M; Detels R; Margolick JB; Riddler SA; Williams CM; Phair JP;
    AIDS; 2005 Jun; 19(9):953-60. PubMed ID: 15905677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alcohol consumption and HIV disease progression.
    Samet JH; Cheng DM; Libman H; Nunes DP; Alperen JK; Saitz R
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):194-9. PubMed ID: 17667330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment.
    Crane HM; McCaul ME; Chander G; Hutton H; Nance RM; Delaney JAC; Merrill JO; Lau B; Mayer KH; Mugavero MJ; Mimiaga M; Willig JH; Burkholder GA; Drozd DR; Fredericksen RJ; Cropsey K; Moore RD; Simoni JM; Christopher Mathews W; Eron JJ; Napravnik S; Christopoulos K; Geng E; Saag MS; Kitahata MM
    AIDS Behav; 2017 Jul; 21(7):1914-1925. PubMed ID: 28285434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study.
    Galvan FH; Bing EG; Fleishman JA; London AS; Caetano R; Burnam MA; Longshore D; Morton SC; Orlando M; Shapiro M
    J Stud Alcohol; 2002 Mar; 63(2):179-86. PubMed ID: 12033694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Number of Drinks to "Feel a Buzz" by HIV Status and Viral Load in Men.
    McGinnis KA; Fiellin DA; Tate JP; Cook RL; Braithwaite RS; Bryant KJ; Edelman EJ; Gordon AJ; Kraemer KL; Maisto SA; Justice AC;
    AIDS Behav; 2016 Mar; 20(3):504-11. PubMed ID: 26936030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda.
    Bajunirwe F; Haberer JE; Boum Y; Hunt P; Mocello R; Martin JN; Bangsberg DR; Hahn JA
    PLoS One; 2014; 9(12):e113152. PubMed ID: 25436894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.